PMC:7784830 / 24092-24224 2 Projects
Annnotations
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T191 | 0-132 | Sentence | denotes | Novavax, Inc Middle East Respiratory Syndrome (MERS) vaccine was developed using recombinant nanoparticle based vaccine technology. |
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T191 | 0-132 | Sentence | denotes | Novavax, Inc Middle East Respiratory Syndrome (MERS) vaccine was developed using recombinant nanoparticle based vaccine technology. |